NIDDK extramural research obligations in Maryland

Maryland crossed with CFDA 93.847

CFDA 93.847 is titled DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH. Filtered to Maryland place of performance, the obligation sum is $906,794,457.19 on 222 awards. The national 93.847 hub still includes other states. Maryland’s spending hub still includes other programs. Only the intersection sits on this page. $906,794,457.19 is an obligation aggregate from USAspending.gov, not an outlay and not a count of NIDDK intramural labs on the NIH campus.

Two hundred twenty-two awards is a multi-project extramural pattern: NIH assistance often posts as many discrete records rather than one statewide block. The join does not name universities, hospitals, or principal investigators. Packet facts stop at $906,794,457.19, 222 awards, MD, and 93.847. Correlation is not causation. FEC donations do not fund this USAspending cell.

93.847 is not NHLBI or NCI in Maryland

Cardiovascular research uses CFDA 93.837. Cancer catalogs use other institute numbers. Mixing those series into $906,794,457.19 would invent a broader biomedical total than this cell contains. Facts available: Maryland, CFDA 93.847, $906,794,457.19, 222 awards. Study titles, activity codes, and publication counts are unpublished.

The catalog title names diabetes, digestive, and kidney extramural research, not a ranking of academic medical centers. Dividing $906,794,457.19 by 222 yields about $4.08 million per award—closer to a multi-year project than to a typical stipend. Unique recipients are unpublished. 222 is not a count of labs or patients.

Place of performance on the NIDDK tag

MD is the place-of-performance code. Awards billed to Baltimore, Bethesda, College Park, or other in-state sites can share the tag. Awards coded to Virginia, the District of Columbia, Pennsylvania, Delaware, or West Virginia stay outside $906,794,457.19 even when a multi-site protocol enrolls across those borders. The code does not convert $906.79 million into a campus map.

Maryland federal spending is the all-program parent. 93.847 is one row on Maryland programs. $906.79 million is not the state’s complete federal footprint. Open Diabetes, Digestive, And Kidney Diseases Extramural Research in Maryland for the filtered table, CFDA 93.847 for the catalog without a Maryland filter, and All spending ties for other pairs. Do not add those parents into $906,794,457.19.

Reading 222 awards under $906.79 million

$906,794,457.19 ÷ 222 is about $4.08 million per award. That average is an extramural-project scale, not a per-patient cost and not a median. Net obligations can include downward modifications; the total shown is the aggregate in the facts. Treat 222 as a record count, not as 222 finished trials or 222 investigators.

USAspending obligations can be positive new awards or net of downward modifications; $906,794,457.19 is the net total supplied in the facts. Without a transaction register, you cannot see how many of the 222 rows are continuations, renewals, or corrections. Later ingests can restate $906,794,457.19 without changing the join key of 93.847 and MD.

What the NIDDK–Maryland pair does not prove

A large 93.847 total tagged to Maryland does not measure whether disease incidence fell, and it does not equal papers published. FEC donations do not fund this USAspending cell. Correlation is not causation. The headline remains $906,794,457.19 on 222 awards for NIDDK extramural research in Maryland.

Keep both sides of the join: Diabetes, Digestive, and Kidney Diseases Extramural Research and Maryland, obligations only. Do not annualize $906,794,457.19 without a year field—this packet publishes none. Do not treat 222 as a PI census. Quote USAspending.gov and the overlay path rather than a discovery story.

Using the NIDDK–Maryland overlay

The overlay target is the Maryland × CFDA 93.847 table. Open Diabetes, Digestive, And Kidney Diseases Extramural Research in Maryland when you want the same $906,794,457.19 / 222-award cell in the site’s data chrome. CFDA 93.847 drops the Maryland filter. Maryland federal spending drops the CFDA filter. Maryland programs lists other catalogs beside 93.847. All spending ties indexes other pairs.

This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that Maryland won or lost federal money, that donations paid for the awards, or that obligations equal cash. The pair is 93.847 plus MD. Obligations of $906,794,457.19 are not outlays.

Questions

How much NIDDK extramural funding is obligated in Maryland?

USAspending records $906,794,457.19 in CFDA 93.847 obligations with Maryland place of performance on 222 awards. That is the pair total, not an outlay and not every NIH CFDA. Keep Diabetes, Digestive, And Kidney Diseases Extramural Research and Maryland together when citing $906,794,457.19.

Does 222 awards mean 222 laboratories in Maryland?

222 is a USAspending award-record count, not a lab or PI census. The implied mean is about $4.08 million per award. Unique recipients and study titles are unpublished. 222 is a record count, not a person or facility census.

Is this Maryland’s total federal research spending?

No. This join is CFDA 93.847 only. Other NIH institute catalogs appear on separate Maryland program pages. Nationwide 93.847 is not limited to Maryland. Obligations of $906,794,457.19 are not outlays. The overlay is the live Diabetes, Digestive, And Kidney Diseases Extramural Research–Maryland table.

Do these obligations equal research completed?

No. $906,794,457.19 is an obligation sum. Outlays are a different USAspending series. Grant drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.847 × MD pair.